Erasto Gaertner

What Erasto Gaertner does

Hospital Erasto Gaertner is the largest cancer treatment center in Paraná and one of the leading oncology centers in Brazil, operated by the Liga Paranaense de Combate ao Câncer (LPCC), a nonprofit civil society entity headquartered at R. Dr. Ovande do Amaral, 201 in Curitiba. The complex delivers comprehensive oncology services — surgical oncology, chemotherapy, radiotherapy, bone marrow transplantation, palliative care, and advanced therapies including CAR-T Cell and robotic surgery — alongside pediatric oncology through the affiliated Hospital Erastinho unit (ages 0–18). Patient volume in 2025 reached over 87 thousand people and 2.752 million procedures, with a reported 70.9% five-year global survival rate.

The business model is a hybrid philanthropic-hospital model: approximately 75% of care is delivered through Brazil's public health system (SUS), which reimburses only around 65% of hospital costs, creating a structural funding gap closed by private health insurance (convênios), individual and corporate donations (Projeto Padrinhos, Presente Solidário), and income-tax-deductible giving programs allowing up to 6% of individual and 1% of corporate income tax to be directed to the institution. Supporting units include IBEG (Instituto de Bioengenharia Erasto Gaertner), the only national manufacturer of fully implantable catheters in Brazil with ANVISA, ISO 9001, and ISO 13485 certifications, and CEPEP, the center for clinical research, residency programs across 13 specialties, and fellowships.

The institution holds Teaching Hospital accreditation since 2004, JCI accreditation, and is the first hospital in the world to simultaneously hold LEED Zero Energy and WELL certifications (Erastinho, 2024), alongside the IWBI Vanguard Award. Revenue is not publicly disclosed; the entity is privately held and not listed, with no venture or private equity ownership indicated in the source data.

Name

Erasto Gaertner

Legal name

Liga Paranaense de Combate ao Câncer

Website

https://erastogaertner.com.br

Company type

Private

Founded year

1972

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Hospital Erasto Gaertner is the largest nonprofit cancer treatment center in Paraná, Brazil, delivering comprehensive adult and pediatric oncology — including CAR-T Cell therapy, robotic surgery, and bone marrow transplant — to over 87,000 patients annually, primarily through Brazil's public health system (SUS) with a manufacturing arm (IBEG) for implantable medical devices.

Ownership category

akta.pro rank

Product category

Oncology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), Offices of Physicians (62111)

SIC

Services-Hospitals (8060), Services-Health Services (8000)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industry

Medical Oncology (HLAKAFAB)

Keywords

• Oncology treatment services
• Cancer care hospital
• Chemotherapy services
• Radiotherapy services
• Bone marrow transplant

Headquarters

HQ city

Curitiba

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. SUS (Sistema Único de Saúde) Revenue: 75% of care provided through Brazil's public health system (SUS), which covers approximately 65% of hospital costs, creating a funding gap that requires additional revenue streams
2. Health Insurance Plans (Convenios): Services provided through private health insurance partnerships
3. Donations and Philanthropy: Donation programs including Projeto Padrinhos (Godparents Project), Presente Solidário (Solidarity Gift), and income tax destination projects
4. Income Tax Donation Projects: Projects allowing individuals to donate up to 6% and companies up to 1% of income tax due to Hospital Erasto Gaertner

Distribution channels4 records

Marketing channels5 records

Core offering

Hospital Erasto Gaertner is an integrated oncology complex providing comprehensive cancer care — including surgical oncology, chemotherapy, radiotherapy, bone marrow transplantation, CAR-T Cell therapy, robotic surgery, and pediatric oncology through the Hospital Erastinho unit. It also operates the IBEG bioengineering institute manufacturing totally implantable catheters and orthopedic/maxillofacial prostheses, the CEPEP teaching and research center, a hospice palliative-care unit, a blood bank, and a benchmarking visit program for external institutions.

Product overview

Hospital Erasto Gaertner operates as an integrated oncology complex comprising the main adult cancer hospital, the Hospital Erastinho pediatric unit, CEPEP research and education center, and the IBEG bioengineering institute. The hospital offers comprehensive cancer care services including surgery, chemotherapy, radiotherapy, bone marrow transplantation, and CAR-T Cell therapy, with approximately 75% of services delivered through Brazil's public healthcare system (SUS). The portfolio includes both direct patient care services and supporting infrastructure such as the hospice palliative care unit, blood bank, and benchmarking visit programs.

Differentiator

Problem solved

Functional benefit

Products and services

• Hospital Erasto Gaertner (Main Oncology Complex) The main oncology hospital complex serving as the largest cancer treatment center in Paraná, Brazil, offering prevention, diagnosis, and treatment services through SUS and private insurance. Includes surgical oncology, chemotherapy, radiotherapy, bone marrow transplantation, and clinical research capabilities.
• Hospital Erastinho (Pediatric Oncology Unit) Pediatric oncology unit of the Erasto Gaertner Complex dedicated to diagnosis and treatment of childhood and adolescent cancer for patients aged 0-18. The first hospital in the world to simultaneously achieve LEED Zero Energy and WELL certifications and recipient of the IWBI Vanguard Award.
• CEPEP - Centro de Projetos de Ensino e Pesquisa Center for Teaching and Research Projects operating across all units of Liga Paranaense de Combate ao Câncer, managing clinical research, medical education programs, fellowships, residency programs, and scientific events supporting the hospital's academic mission.
• IBEG - Instituto de Bioengenharia Erasto Gaertner Bioengineering institute focused on developing and manufacturing orthopedic prostheses, maxillofacial devices, totally implantable venous catheters, and vacuum immobilization systems. The only national manufacturer of totally implantable catheters in Brazil, certified under ANVISA Good Manufacturing Practices, ISO 9001:2000, and ISO 13485:2003.
• Hospice Erasto Gaertner Palliative care unit providing end-of-life care and support for cancer patients, focusing on quality of life, dignity, and symptom management.
• Banco de Sangue (Blood Bank) Hospital blood bank service providing blood products and transfusion support for oncology patients undergoing treatment.
• Quimioterapia (Chemotherapy) Oncology chemotherapy service administering antineoplastic medications for cancer treatment.
• Radioterapia (Radiotherapy) Radiation therapy service providing external beam radiotherapy and brachytherapy treatments for cancer patients.
• TMO - Transplante de Medula Óssea (Bone Marrow Transplant) Bone marrow transplant service performing stem cell transplants for hematologic malignancies and other conditions (49 transplants performed at Hospital Erastinho in 2025).
• CAR-T Cell Therapy Advanced cellular immunotherapy treatment using genetically modified T-cells for eligible cancer patients (4 therapies performed at Hospital Erastinho in 2025).
• Visitas de Benchmarking (Benchmarking Visits) Structured benchmarking visit program allowing companies, hospitals, and institutions to observe operational aspects, functions, and physical facilities of the hospital complex.

Quantifiable outcome

• 70.9% global survival rate - after 5 years, 7 in 10 patients are free of active disease
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• Rede Feminina de Combate ao Câncer (RFCC)coreStrategic or Co-development PartnerWomen's Network to Fight Cancer - a volunteer organization that supports the hospital's mission through charitable activities and community engagement. Part of the Liga Paranaense de Combate ao Câncer network.
• IBEG - Instituto de Bioengenharia Erasto GaertnercoreStrategic or Co-development PartnerBioengineering Institute - operational unit of Erasto Gaertner focused on development and manufacturing of orthopedic prostheses, maxillofacial implants, venous catheters, and hospital materials. Only national manufacturer of totally implantable catheters.
• Hospital ErastinhocoreStrategic or Co-development PartnerPediatric oncology unit of Erasto Gaertner treating children and adolescents aged 0-18 years. The first hospital in the world to achieve both LEED Zero Energy and WELL certifications.

Scale indicators16 records

Recent moves6 records

Expansion highlights6 records

Market position

Competitive moat6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/HospErastoGaertner
• Facebookfacebook.com/HospitalErastoGaertner
• Instagraminstagram.com/hospitalerastogaertner
• Xx.com/herastogaertner

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Erasto Gaertner